Answer
Nonacog gamma (Rixubis), used as factor IX substitution therapy, may increase cardiovascular risk in patients with existing cardiovascular risk factors.
Sources for this answer
- RIXUBIS 1000 IU and 2000 IU powder and solvent for solution for injectionTakeda UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked